DELRAY BEACH, Fla., May 04, 2016 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its E-N-G Mobile Systems (“ENG”) subsidiary has launched a new website at www.e-n-g.com.
ENG is a leading manufacturer of specialty vehicles, with a focus on mobile labs, with more than 400 labs delivered to federal, state and local agencies, and private companies. ENG was the first company to install gas chromatography (“GC”) in a mobile laboratory, and is a pioneer in developing mobile platforms that allow standard laboratory-grade instruments to be operated successfully in the field.
Scientific and environmental agencies choose ENG’s MobiLab™ systems due to their productivity in the field. Applications range from general purpose and chemistry labs, to BSL 3-ready and full CBRNE threat detection and analysis.
In addition to mobile labs, ENG has delivered more than 1,400 specialty vehicles to customers around the globe. These include communications/command centers, broadcast news vehicles, radio frequency monitoring, infrared monitoring and video communications vehicle systems, plus a wide range of mobile systems for emergency preparedness and threat response.
About PositiveID Corporation
PositiveID Corporation is a life sciences tools and diagnostics company with an extensive patent portfolio. PositiveID develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID is also a leader in the mobile technology vehicle market, with a focus on the laboratory market and homeland security. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
Statements about PositiveID's future expectations, including the likelihood that scientific and environmental agencies choose ENG’s MobiLab systems due to their productivity in the field; constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to target the bio-threat detection, rapid medical testing, and specialty vehicle sectors; the Company’s ability to successfully integrate the ENG acquisition; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 12, 2016, and 10-Qs filed on November 12, 2015, August 13, 2015, and May 15, 2015, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.